Cargando…
Lopinavir/ritonavir: Maculopapular rash following off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530852/ http://dx.doi.org/10.1007/s40278-020-84147-3 |
Ejemplares similares
-
Maculopapular rash in COVID-19 patient treated with lopinavir/ritonavir
por: Mazan, Paula, et al.
Publicado: (2020) -
Lopinavir/ritonavir: Hyperlipidaemia following off-label use: case report
Publicado: (2020) -
Lopinavir/ritonavir: Bradyarrhythmia following an off-label use : case report
Publicado: (2020) -
Lopinavir/ritonavir: Diarrhoea following off label use: case report
Publicado: (2021) -
Favipiravir: Maculopapular rash, urticarial rash and Stevens–Johnson syndrome following off label use: 5 case reports
Publicado: (2022)